Robert E. Gagnon

Chief Financial Officer, Opus Genetics, Inc.; Director, Verastem, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Oct 23, 2026

Companies

Opus Genetics, Inc.Chief Financial Officer −$0.2M Verastem, Inc.Director −$0.0M

Trades

IRD Sold 14,000 shares at $3.55 · planned $0.0M Oct 23

IRD Sold 28,000 shares at $4.54 · planned $0.1M Sep 3

IRD Sold 7,783 shares at $2.95 $0.0M Jul 23

IRD Sold 7,842 shares at $5.18 $0.0M Apr 23

VSTM Sold 283 shares at $9.14 · planned $0.0M Dec 16

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.